(R)-(-)-3-Carbamoymethyl-5-Methylhexanoic Acid CAS 181289-33-8 Purity>99.0% (HPLC) Pregabalin Intermediate Factory
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (R)-(-)-3-Carbamoymethyl-5-Methylhexanoic Acid (CAS: 181289-33-8) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available, strong after-sale service. Welcome to order. Please contact: alvin@ruifuchem.com
| Gemyske namme | (R)-(-)-3-Carbamoymethyl-5-Methylhexanoic Acid |
| Synonimen | (R)-3-(2-Amino-2-Oxoethyl)-5-Methylhexanoic acid;RCMH;Pregabalin ûnreinheid III |
| CAS nûmer | 181289-33-8 |
| CAT nûmer | RF-CC307 |
| Stock Status | Op foarried, produksjeskaal oant tonnen |
| Molekulêre formule | C9H17NO3 |
| Molekuul gewicht | 187.24 |
| Merk | It bedriuw Ruifu Chemical |
| Items | Spesifikaasjes | Results |
| Skaaimerken | Wyt of Off-White Crystalline Poeder | Conforms |
| Assay (Titraasje) | Mear dan 99,0% | 99.55% |
| Identifikaasje | IR & HPLC | Conforms |
| Purity / Analyse metoade | mear as 99,0% (HPLC) | 99.71% |
| Smeltpunt | 126.0~133.0℃ | 129,1 ~ 131,5 ℃ |
| S-Isomer | Minder as 1,00% | 0.28% |
| A-Phenylethylamine | Minder dan 0,50% | Conforms |
| Dicarbonzuur | Minder dan 0,30% | Conforms |
| Any Single Unreinheit | Minder dan 0,50% | Conforms |
| Ferlies op Drying | Minder as 1,00% | 0.38% |
| Residu op Ignition | Minder dan 0,30% | 0.022% |
| Test Standert | Enterprise Standert | |
| Gebrûk | Intermediate of Pregabalin (CAS: 148553-50-8) | |
Pakket: Fleske, aluminium folie tas, 25 kg / kartonnen trommel, of neffens klant syn eask
Opslach betingst:Bewarje yn fersegele konteners op in koel en droech plak;Beskermje fan ljocht en focht
(R)-(-)-3-Carbamoymethyl-5-Methylhexanoic Acid (CAS: 181289-33-8) is in nuttich gemysk intermediate foar it meitsjen fan it anticonvulsive medisyn, Pregabalin (CAS: 148553-50-8).Pregabalin is in nij anty-epileptysk medisyn, mei in molekulêre struktuer fan γ-amino butyric acid, dat hat anticonvulsant effekten, en is mei súkses ûntwikkele troch it bedriuw Pfizer foar de behanneling fan perifeare neuropathyske pine, as adjuvante behanneling fan parsjele seizures.Pregabalin is in twadde generaasje anty-epileptysk medisyn (AED) bekend mei de eigen merknamme fan Lyrica (Pfizer, Tadworth) yn it Feriene Keninkryk en FS (Pfizer, New York, NY).
